Cachet Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002462.SZ

Cachet Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023: 5.90%

Cachet Pharmaceutical Co., Ltd. Return on Equity (ROE) is 5.90% for the year ending December 31, 2023, a -48.65% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Cachet Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 11.48%, a -25.84% change year over year.
Cachet Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was 15.49%, a -4.89% change year over year.
Cachet Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 16.28%, a -15.46% change year over year.
Cachet Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2019 was 19.26%, a 46.81% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Shenzhen Stock Exchange: 002462.SZ

Cachet Pharmaceutical Co., Ltd.

CEO	Mr. Yibin Huang
IPO Date	Aug. 18, 2010
Location	China
Headquarters	Building 1
Employees	2,357
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale

Description

Cachet Pharmaceutical Co., Ltd. engages in the wholesale and retail sale of pharmaceutical products in China. It is involved in the supply of medicines to hospitals; wholesale of biological products, medical instruments, and traditional Chinese medicines; pharmaceutical logistic operations; and manufacture of medicines. The company owns 150 chain stores in Beijing that sell medicines, health care foods, medical instruments, cosmetics, daily necessities, and traditional Chinese medicines. Cachet Pharmaceutical Co., Ltd. was founded in 1998 and is based in Beijing, China.

Key trends

Past 5 years